Research Projects & Grants

For Profit Organization

• All to target trial lantus® (insulin glargine) with stepwise addition of APIDRA® (insulin glulisine) or Lantus with one injection of Apidra vs. a twice-daily premixed insulin regimen (Novolog® mix 70/30™) in adult subjects with type 2 diabetes failing dual or triple therapy with oral agents: a 64-week, multi-center, randomized, parallel, open-label clinical study. Protocol No. HMR 1964A/3515, Role: Investigator, Sanofi-Synthelabo Pharmaceuticals, (05/2008 - 05/2009) Status: Completed
• A multicenter, randomized, double-blind, active controlled study to compare the effect of 24 weeks treatment with vildagliptin 100 mg qd or metformin 1500 mg daily in elderly drug naïve patients with type 2 diabetes LAF237/vildagliptin Protocol number CLAF237A2398, Role: Investigator, Novartis Pharmaceuticals Corporation, (08/2007 - 08/2008) Status: Completed